Many recent NACDS RxIMPACT pharmacy tours have been directly with members of Congress themselves—68 percent so far this year.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.
NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.